Search results

IRS issues guidance on calculation of the annual fee imposed on manufacturers and importers of branded prescription drugs under the Affordable Care Act

• Reed Smith LLP
• -
• USA
• -
• December 17 2010

On November 29, 2010, the Internal Revenue Service (the "IRS") issued Notice 2010-71, 2010-50 IRB (the "Notice"), which provides guidance on the calculation of the annual fee imposed on certain manufacturers and importers of branded prescription drugs for calendar years beginning after December 31, 2010, pursuant to the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the Affordable Care Act or the "ACA"